These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36337804)

  • 21. Pattern of hemoglobinopathies and thalassemias in upper Assam region of North Eastern India: high performance liquid chromatography studies in 9000 patients.
    Baruah MK; Saikia M; Baruah A
    Indian J Pathol Microbiol; 2014; 57(2):236-43. PubMed ID: 24943756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemoglobin Variants Acquired Post-Exchange Transfusion in Pediatric Sickle Cell Disease (SCD) Patients.
    Pandey S; Cottler-Fox M; Drobena G
    Ann Clin Lab Sci; 2015; 45(6):627-30. PubMed ID: 26663791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Human β-Globin Gene Variant [Hb London-Ontario,
    Bienz MN; Hsia C; Waye JS; Bode M; Solh Z
    Hemoglobin; 2019 Mar; 43(2):129-131. PubMed ID: 31246535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin disorders in South India.
    Chandrashekar V; Soni M
    ISRN Hematol; 2011; 2011():748939. PubMed ID: 22084704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Hematological Indices as a Screening Tool of Beta Thalassemia Trait in Eastern Uttar Pradesh: An Institutional Study.
    Bhargava M; Kumar V; Pandey H; Singh V; Misra V; Gupta P
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):719-724. PubMed ID: 33100716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of hemoglobin H disease by sickle trait.
    Matthay KK; Mentzer WC; Dozy AM; Kan YW; Bainton DF
    J Clin Invest; 1979 Oct; 64(4):1024-32. PubMed ID: 479366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.
    Moassas F; Nweder MS; Murad H
    BMC Pediatr; 2019 Feb; 19(1):61. PubMed ID: 30777047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patients.
    Papassotiriou I; Voskaridou E; Stamoulakatou A; Loukopoulos D
    Hematol J; 2000; 1(5):295-300. PubMed ID: 11920206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Characterization of δ-Thalassemia in Iran.
    Kordafshari A; Amirian A; Zeinali S; Valaei A; Maryami F; Karimipoor M
    Hemoglobin; 2016; 40(1):44-7. PubMed ID: 26754299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients.
    Shome DK; Al Ajmi A; Radhi AA; Mansoor EJ; Majed KS
    Indian J Hematol Blood Transfus; 2016 Mar; 32(1):104-9. PubMed ID: 26855516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hemoglobinopathy disorders in adult patients sent for diagnosis of anemia in saudi arabia.
    Alsaeed AH
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):25-9. PubMed ID: 21861712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.
    Oudat RI; Abualruz HS; Al-Shiek NKA; Al-Mashaqba EA; Al-Hiari RA; Alsoukhni HA; Hammad MAA
    Med Arch; 2021 Feb; 75(1):27-30. PubMed ID: 34012195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
    Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
    Balgir RS
    J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coinheritance of hemoglobin D-Punjab and β
    Panyasai S; Rahad S; Pornprasert S
    Asian J Transfus Sci; 2017; 11(2):199-202. PubMed ID: 28970692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of anemia and hemoglobinopathies in the hematologic clinics of the kermanshah province, Western iran.
    Payandeh M; Rahimi Z; Zare ME; Kansestani AN; Gohardehi F; Hashemian AH
    Int J Hematol Oncol Stem Cell Res; 2014; 8(2):33-7. PubMed ID: 24800037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.